Corresponding Author: Charles R. Marmar, MD, Psychiatry Department, NYU Langone Medical Center, 1 Park Ave, 8th Floor, New York, NY 10016 (charles.marmar@nyumc.org).
Published Online: October 12, 2020. doi:10.1001/jama.2020.19632
Conflict of Interest Disclosures: Dr Simon reported receiving research grants from the American Foundation for Suicide Prevention, Department of Defense, Patient-Centered Outcomes Research Institute, the Highland Street Foundation, the National Institute of Mental Health (NIMH), the National Center for Complementary and Integrative Health, and the Cohen Veterans Network; personal fees from Vanda Pharmaceuticals Inc, MGH Psychiatry Academy, Axovant Sciences, Springworks, Praxis Therapeutics, Aptinyx, Genomind, and Wiley (deputy editor, Depression and Anxiety); spousal equity from G1 Therapeutics; and royalties from Wolters Kluwer (UpToDate) and APA Press (Simon, Hollander, Rothbaum, & Stein, The APA Publishing Textbook of Anxiety, Trauma and OCD Related Disorders, 2020). Dr Saxe reported receiving NIMH grant R01MH119114 (Dr Saxe, principal investigator [PI]), Substance Abuse and Mental Health Services Administration grants U79SM080049 (Dr Saxe, PI) and U79SM080013 (Julian Ford, PI), and royalties from Guilford Press for the book Trauma Systems Therapy for Children and Teens (2016). Dr Marmar reported receiving support from the National Institute on Alcohol Abuse and Alcoholism, the NIMH, Department of Defense, US Army Congressionally Directed Medical Research Program, the Steven and Alexandra Cohen Foundation, Cohen Veterans Bioscience, Cohen Veterans Network, the Home Depot Foundation, the McCormick Foundation, the Robin Hood Foundation, and New York City. He serves on the scientific advisory board and owns equity in Receptor Life Sciences and on the PTSD advisory board for Otsuka Pharmaceutical.
1.Woolf
SH , Chapman
DA , Sabo
RT , Weinberger
DM , Hill
LJ , Taylor
DDH . Excess deaths from COVID-19 and other causes, March-April 2020.
JAMA. Published October 20, 2020. doi:
10.1001/jama.2020.19545Google Scholar 2.Czeisler
MÉ , Lane
RI , Petrosky
E ,
et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic: United States, June 24-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(32):1049-1057. doi:
10.15585/mmwr.mm6932a1
PubMedGoogle ScholarCrossref 6.Verdery
AM , Smith-Greenaway
E , Margolis
R , Daw
J . Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States.
Proc Natl Acad Sci U S A. 2020;117(30):17695-17701. doi:
10.1073/pnas.2007476117PubMedGoogle ScholarCrossref